Skip to main content
Premium Trial:

Request an Annual Quote

Inno-train Diagnostik, Jeta Molecular Ink Marketing, Distribution Deal

NEW YORK (GenomeWeb) – Inno-train Diagnostik, a German molecular kit developer, has signed a distribution and codevelopment agreement with Dutch reagent and software maker Jeta Molecular, the firms announced today. Both firms provide PCR products focused on the transplant monitoring market.

Under the agreement, Inno-train will distribute Jeta's qPCR reagent and software suite, called QTRACE, in the US and in most of Europe excluding France. In addition, the companies plan to codevelop new diagnostic applications, according to a statement. The financial terms of the deal were not disclosed.

Headquartered in Kronberg, Germany, and with a US subsidiary in Clinton, NY, Inno-train Diagnostik designs, develops, and commercializes molecular kits, reagents, and systems for the transplant and transfusion markets, as well as TaqMan PCR kits and systems for HLA-, red blood cell-, and HPA-typing.

Jeta Molecular develops and commercializes reagent and software solutions for transplant monitoring from its headquarters in Utrecht, the Netherlands. Its QTRACE Analysis System is intended for the quantitative measurement of recipient-derived, genomic DNA from white blood cells in peripheral blood or bone marrow to help monitor response to hematopoietic stem cell transplantation.

The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.